Rare Diseases

Intrexon through collaboration is working on the development of DNA-based therapeutics for rare diseases. Our platform has the capability to repair or replace "broken" genes in rare diseases and enable increased production or suppression of proteins to alleviate the downstream effects of their deficiency or over-expression.